SH2B3 and hematologic disorder: Because the coexistence of a driver clone and the acquisition of additional mutations have been identified repeatedly in hematologic malignancies, further studies are required to elucidate how SH2B3—GATA1 and NOTCH1—STAG2 mutations contribute to the pathogenesis of hypereosinophilia.